STIM

#4006
Neuronetics, Inc. Common Stock
1.43 USD
+2.88%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.43
1.43
Faixa anual
0.80
4.82
Mudança diária
+2.88%
Mudança mensal
+5.93%
Mudança em 6 meses
-51.69%
Mudança anual
-62.37%
Fechamento anterior
1.39
Abrir
1.43
Bid
Ask
Mínimo
1.43
High
1.43
Volume
29
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Notícias